My take on the much-touted ‘SafeCell’ paper on adult stem cell safety: encouraging, but some important reservations
The so-called “SafeCell” paper from the journal PLoS One is one that a number of advocates of deregulation of the stem cell industry often have mentioned to me: Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis […]